Join Now

Category Archives: BioUtah News

ARUP Researchers’ Prolific Publications, Presentations Helped Advance Lab Medicine in 2021

By Natalie Themm | Published February 17, 2022

Researchers at ARUP Laboratories made significant contributions to the advancement of laboratory medicine in 2021 as coauthors of more than 150 peer-reviewed articles in academic journals, medical guideline updates, and book chapters. They also contributed more than 40 posters or presentations at national and international medical conferences. Links to each of the 2021 publications and […]

| Tagged | Leave a comment

PolarityTE Announces Allowance of Fourth U.S. Patent

By Natalie Themm | Published February 17, 2022

PolarityTE, Inc. announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice of Allowance for U.S. Application No. 17/326,734 filed on May 21, 2021.

| Tagged | Leave a comment

ARUP Laboratories Is Ranked Among America’s Best Midsize Employers by Forbes

By Natalie Themm | Published February 17, 2022

ARUP’s commitment to creating a satisfying work environment for employees has earned it a spot on Forbes’ list of America’s Best Midsize Employers for 2022.

| Tagged , | Leave a comment

Nexus Spine Appoints Steve Cichy as Vice President of Sales

By Natalie Themm | Published February 17, 2022

Appointment further expands leadership team to support aggressive commercialization of the company’s PressON™ fixation, Tranquil™ interbody, and pending technologies

| Tagged | Leave a comment

Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System

By Natalie Themm | Published February 16, 2022

FDA-Cleared REMI Platform to Begin Initial Commercialization to Hospitals for Use in Emergency Departments and Intensive Care Units Across the United States

| Tagged | Leave a comment

IONIQ Sciences 2021 Year-End Update

By admin | Published February 10, 2022

Originally published by IONIQ Sciences Dear IONIQ Sciences Shareholders and Friends, Greetings from IONIQ Sciences where we continue to follow the science and invest in exceptional team members, advisors and consultants to help us modernize early-stage cancer detection.  LUNG Cancer – we have submitted our application to the FDA!! We have formally submitted our De Novo application to […]

| Leave a comment

Stanford Researchers cite BioPharm Laboratories High Purity Thrombin

By Natalie Themm | Published February 10, 2022

BioPharm Laboratories, another journal article from the Journal of Biological Chemistry cites the use of BioPharm’s High Purity Thrombin being used to cleave protein in their protein purification process.

| Tagged | Leave a comment

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load Test

By Natalie Themm | Published February 10, 2022

SALT LAKE CITY, Feb. 3, 2022 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central […]

| Tagged , | Leave a comment

Co-Diagnostics, Inc. to Host Booth at Life Sciences Day on the Hill on February 16 at the Utah State Capital

By Natalie Themm | Published February 10, 2022

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that it will be hosting a booth at the upcoming Life Sciences Day on the Hill on February 16, 2022, at the Utah State Capital Building. It is expected that the conference, […]

| Tagged , | Leave a comment

Nelson Labs Launches Verification Program to Help Consumers Identify Properly Tested Masks and Respirators

By Natalie Themm | Published February 10, 2022

New Nelson Labs Mark offers transparency and confidence in product testing

| Tagged | Leave a comment

IONIQ Sciences submits De Novo application to FDA for IONIQ ProLung Test

By admin | Published February 3, 2022

Salt Lake City, UT, February 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that it has filed a De Novo application with the U.S. Food and Drug Administration (the “FDA”) for its IONIQ ProLung Test™ used for lung cancer. Mr. Jared Bauer, IONIQ Sciences CEO, stated, “Today we submitted our De […]

| Leave a comment

Fluidx Medical’s Embolic Demonstrates Novel Visibility Advantage

By Natalie Themm | Published February 2, 2022

Fluidx Medical Reports Initial Research on First-of-its-Kind Embolic Agent with Intermediate Radiopacity

| Tagged , | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members